Other OTC - Delayed Quote USD

Enzon Pharmaceuticals, Inc. (ENZN)

0.0780 +0.0056 (+7.75%)
At close: April 23 at 11:07 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
26.0000
701.0000
52.0000
Operating Expense
1,044.0000
1,044.0000
1,058.0000
1,170.0000
1,357.0000
Operating Income
-1,044.0000
-1,044.0000
-1,032.0000
-469.0000
-1,305.0000
Net Non Operating Interest Income Expense
2,261.0000
2,261.0000
646.0000
--
--
Other Income Expense
--
--
646.0000
7.0000
1.0000
Pretax Income
1,217.0000
1,217.0000
-386.0000
-462.0000
-1,304.0000
Tax Provision
-156.0000
-156.0000
-200.0000
7.0000
7.0000
Net Income Common Stockholders
98.0000
98.0000
-1,461.0000
-2,492.0000
-1,771.0000
Diluted NI Available to Com Stockholders
98.0000
98.0000
-1,461.0000
-2,492.0000
-1,771.0000
Basic EPS
0.00
--
-0.02
-0.03
-0.03
Diluted EPS
0.00
--
-0.02
-0.03
-0.03
Basic Average Shares
74,215.0000
--
74,215.0000
74,215.0000
51,100.0000
Diluted Average Shares
74,215.0000
--
74,215.0000
74,215.0000
51,100.0000
Total Operating Income as Reported
-1,044.0000
-1,044.0000
-1,032.0000
-469.0000
-1,305.0000
Total Expenses
1,044.0000
1,044.0000
1,058.0000
1,170.0000
1,357.0000
Net Income from Continuing & Discontinued Operation
1,373.0000
1,373.0000
-186.0000
-469.0000
-1,311.0000
Normalized Income
1,373.0000
1,373.0000
-186.0000
-469.0000
-1,311.0000
Interest Income
2,261.0000
2,261.0000
646.0000
--
--
Net Interest Income
2,261.0000
2,261.0000
646.0000
--
--
EBIT
-1,044.0000
-1,044.0000
-1,032.0000
-469.0000
-1,305.0000
EBITDA
-1,044.0000
-1,044.0000
-1,032.0000
-469.0000
-1,305.0000
Net Income from Continuing Operation Net Minority Interest
1,373.0000
1,373.0000
-186.0000
-469.0000
-1,311.0000
Normalized EBITDA
-1,044.0000
-1,044.0000
-1,032.0000
-469.0000
-1,305.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
12/31/2020 - 2/15/1984

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EVEz.XC
 
ESLA Estrella Immunopharma, Inc.
1.0300
+1.98%
 
ENDV Endonovo Therapeutics, Inc.
0.0025
0.00%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1979
0.00%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
0.2506
-0.56%
 
DYAI Dyadic International, Inc.
1.4900
-2.61%
 
CALC CalciMedica, Inc.
4.5900
+5.76%
 
TBPH Theravance Biopharma, Inc.
9.22
-2.54%
 
CALTX.ST Calliditas Therapeutics AB (publ)
100.40
+0.10%
 
TTNP Titan Pharmaceuticals, Inc.
7.01
0.00%